Together, they produce a GH elevation greater than either alone, with CJC-1295 human clinical trial data confirming mean GH concentrations increasing 2 to 10-fold and IGF-1 levels rising 1.5 to 3-fold following GHRH-analogue administration
That process is slow, and for some people it is not very efficient
For hair restoration, GHK-Cu can be combined with treatments that target circulation, follicle health, and hormones
Low dead space syringes reduce this waste significantly
Works synergistically with tranexamic acid for enhanced brightening
Some possible long-term risks may include: Reduced sensitivity to growth hormone over time Small changes in insulin or blood sugar levels Higher IGF-1 levels, which may affect cell growth These effects are uncommon but worth watching